Latest Valuation News

Pengana International Equities Limited has announced an on-market buy-back of up to 25.7 million ordinary shares, signaling a strategic capital management move without requiring shareholder approval.

Aurum Resources has reported impressive high-grade gold intercepts at its Napié Gold Project in Côte d’Ivoire, extending mineralisation depth and reinforcing its growth ambitions. The company is advancing a large-scale drilling campaign and plans key resource updates and a Pre-Feasibility Study by year-end.

US Masters Residential Property Fund reported robust first-half sales and significant debt reduction, while navigating a modest portfolio valuation dip primarily in New York.

Mount Gibson Iron has extended its on-market share buy-back program for another year, allowing up to 10% of issued shares to be repurchased. Since inception, the company has bought back 3.2% of its shares, signaling ongoing capital management efforts.

NSX Limited shareholders will decide on a recommended acquisition scheme offering $0.04 cash per fully paid share, representing a substantial premium. The Board and an independent expert endorse the deal, which would see NSX delisted and become a CNSX subsidiary.

Following the $75 million sale of its Robe Mesa Iron Ore Project, CZR Resources announces the vesting of nearly 5 million options and performance rights, opening the door to potential share conversions.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

Trading in Jindalee Lithium Limited shares has resumed following the company’s announcement of a potential merger, signaling a pivotal moment for the lithium miner.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Ora Banda Mining's latest drilling at Sand King Underground reveals significant high-grade gold mineralisation 300 metres beyond current life of mine plans, expanding the resource footprint and boosting production potential.

News Corporation has announced a significant secondary offering of over 14 million Class B shares by key family trusts, signaling a notable insider sell-down without direct proceeds to the company.